{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:10:54Z","timestamp":1790838654581,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["LUAUS23275"],"award-info":[{"award-number":["LUAUS23275"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","award":["INTER-ACTION-LUAUS23"],"award-info":[{"award-number":["INTER-ACTION-LUAUS23"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Czech Science Foundation","doi-asserted-by":"publisher","award":["22-05318S"],"award-info":[{"award-number":["22-05318S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014911","name":"Ministry of Defence and Armed Forces of the Czech Republic","doi-asserted-by":"publisher","award":["DZRO-FVZ22-ZHN II"],"award-info":[{"award-number":["DZRO-FVZ22-ZHN II"]}],"id":[{"id":"10.13039\/501100014911","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.neuropharm.2024.110171","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T22:37:42Z","timestamp":1727822262000},"page":"110171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Midazolam - A diazepam replacement for the management of nerve agent-induced seizures"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4791-6556","authenticated-orcid":false,"given":"Lukas","family":"Gorecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Pejchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carilyn","family":"Torruellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Korabecny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Soukup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.110171_bib1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1017\/S1049023X00001072","article-title":"Future considerations for the medical management of nerve-agent intoxication","volume":"18","author":"Aas","year":"2003","journal-title":"Prehospital Disaster Med."},{"key":"10.1016\/j.neuropharm.2024.110171_bib2","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1476-5381.2009.00330.x","article-title":"Bioavailability of diazepam after intramuscular injection of its water-soluble prodrug alone or with atropine-pralidoxime in healthy volunteers","volume":"157","author":"Abbara","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa002141","article-title":"A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus","volume":"345","author":"Alldredge","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2024.110171_bib4","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.3390\/jcm10081754","article-title":"Time is brain: acute control of repetitive seizures and status epilepticus using alternative routes of administration of benzodiazepines","volume":"10","author":"Almohaish","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuropharm.2024.110171_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/jpet.114.217299","article-title":"The limitations of diazepam as a treatment for nerve agent\u2013induced seizures and neuropathology in rats: comparison with UBP302","volume":"351","author":"Apland","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.110171_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108298","article-title":"Acetylcholinesterase inhibitors (nerve agents) as weapons of mass destruction: history, mechanisms of action, and medical countermeasures","volume":"181","author":"Aroniadou-Anderjaska","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.110171_bib7","article-title":"Targeting the glutamatergic system to counteract organophosphate poisoning: a novel therapeutic strategy","volume":"133","author":"Aroniadou-Anderjaska","year":"2020","journal-title":"Neurobiol. Dis., Discovery and development of better medical countermeasures for chemical threats targeting the nervous system"},{"key":"10.1016\/j.neuropharm.2024.110171_bib9","series-title":"Chemical, Biological, Radiological and Nuclear (CBRN) Injury Part I: Initial Response to CBRN Agents (CPG ID: 69)","author":"Barbee","year":"2018"},{"key":"10.1016\/j.neuropharm.2024.110171_bib8","article-title":"Chemical, Biological, Radiological and Nuclear (CBRN) Injury Response Part 2","author":"Barbee","year":"2019","journal-title":"Medical Management of Chemical Agent Exposure (CPG ID:69)"},{"key":"10.1016\/j.neuropharm.2024.110171_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0920-1211(91)90011-4","article-title":"A comparative pharmacokinetic study of intravenous and intramuscular midazolam in patients with epilepsy","volume":"10","author":"Bell","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2024.110171_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yebeh.2017.02.023","article-title":"Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: randomized study in healthy geriatric and non-geriatric adults","volume":"71","author":"Berg","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2024.110171_bib12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"Bialer","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2024.110171_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00003088-199835010-00003","article-title":"Clinical pharmacology of midazolam in infants and children","volume":"35","author":"Blumer","year":"1998","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.neuropharm.2024.110171_bib14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s40262-014-0166-x","article-title":"Midazolam pharmacokinetics in morbidly obese patients following semi-simultaneous oral and intravenous administration: a comparison with healthy volunteers","volume":"53","author":"Brill","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.neuropharm.2024.110171_bib15","first-page":"521","article-title":"Effects of atropine sulphate on seizure activity and brain damage produced by soman in Guinea-pigs: ECoG correlates of neuropathology","volume":"21","author":"Carpentier","year":"2000","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2024.110171_bib16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.clpt.2006.08.014","article-title":"Sex differences in CYP3A activity using intravenous and oral midazolam","volume":"80","author":"Chen","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2024.110171_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.taap.2011.07.003","article-title":"Nerve agent intoxication: recent neuropathophysiological findings and subsequent impact on medical management prospects","volume":"255","author":"Collombet","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib18","doi-asserted-by":"crossref","unstructured":"Cornett, E.M., Nemomsa, M.A., Turbeville, B., Busby, M.A., Kaye, J.S., Kaye, A.J., Choi, J., Ram\u00edrez, G.F., Varrassi, G., Kaye, A.M., Kaye, A.D., Wilson, J., Ganti, L., n.d. Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review. Health Psychol. Res. 10, 38536. https:\/\/doi.org\/10.52965\/001c.38536.","DOI":"10.52965\/001c.38536"},{"key":"10.1016\/j.neuropharm.2024.110171_bib19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.bdj.4800470a","article-title":"The effects of midazolam and flumazenil on psychomotor function and alertness in human volunteers","volume":"188","author":"Coulthard","year":"2000","journal-title":"Br. Dent. J."},{"key":"10.1016\/j.neuropharm.2024.110171_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/nyas.14331","article-title":"Electroencephalographic analysis in soman-exposed 21-day-old rats and the effects of midazolam or LY293558 with caramiphen","volume":"1479","author":"De Araujo Furtado","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2024.110171_bib21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1124\/jpet.123.001710","article-title":"Preventing long-term brain damage by nerve agent\u2013induced status epilepticus in rat models applicable to infants: significant neuroprotection by tezampanel combined with caramiphen but not by midazolam treatment","volume":"388","author":"De Araujo Furtado","year":"2024","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.110171_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuro.2014.04.006","article-title":"Development of status epilepticus, sustained calcium elevations and neuronal injury in a rat survival model of lethal paraoxon intoxication","volume":"44","author":"Deshpande","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2024.110171_bib23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s002040050188","article-title":"Assessment of primary neuronal culture as a model for soman-induced neurotoxicity and effectiveness of memantine as a neuroprotective drug","volume":"69","author":"Deshpande","year":"1995","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-94-017-8914-1_9","article-title":"When and how do seizures kill neurons, and is cell death relevant to epileptogenesis?","volume":"813","author":"Dingledine","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1213\/00000539-198301000-00001","article-title":"Absolute bioavailability of oral and intramuscular diazepam: effects of age and sex","volume":"62","author":"Divoll","year":"1983","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2024.110171_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cbi.2012.09.013","article-title":"Ketamine combinations for the field treatment of soman-induced self-sustaining status epilepticus. Review of current data and perspectives","volume":"203","author":"Dorandeu","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.neuropharm.2024.110171_bib27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev-pharmtox-010818-021842","article-title":"Novel clinical toxicology and pharmacology of organophosphorus insecticide self-poisoning","volume":"59","author":"Eddleston","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib28","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0140-6736(05)67598-8","article-title":"Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study","volume":"366","author":"Eddleston","year":"2005","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.neuropharm.2024.110171_bib29","unstructured":"FDA Approves New Drug Application for the DoD\u2019s Advanced Anticonvulsant System Program [WWW Document], n.d. . JPEO-CBRND. URL https:\/\/www.jpeocbrnd.osd.mil\/Media\/News\/Article\/3137708\/fda-approves-new-drug-application-for-the-dods-advanced-anticonvulsant-system-p\/https%3A%2F%2Fwww.jpeocbrnd.osd.mil%2FMedia%2FNews%2FArticle%2F3137708%2Ffda-approves-new-drug-application-for-the-dods-advanced-anticonvulsant-system-p%2F (accessed 2.6.23)."},{"key":"10.1016\/j.neuropharm.2024.110171_bib30","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/15353702231171911","article-title":"Delayed tezampanel and caramiphen treatment but not midazolam protects against long-term neuropathology after soman exposure","volume":"248","author":"Figueiredo","year":"2023","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.neuropharm.2024.110171_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3390\/toxics10080409","article-title":"Antiseizure and neuroprotective efficacy of midazolam in comparison with tezampanel (LY293558) against soman-induced status epilepticus","volume":"10","author":"Figueiredo","year":"2022","journal-title":"Toxics"},{"key":"10.1016\/j.neuropharm.2024.110171_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eplepsyres.2010.10.001","article-title":"Diazepam autoinjector intramuscular delivery system versus diazepam rectal gel: a pharmacokinetic comparison","volume":"93","author":"Garnett","year":"2011","journal-title":"Epilepsy Res."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2024.110171_bib33","first-page":"S34","article-title":"Rescue therapies for seizure clusters: pharmacology and target of treatments","volume":"63","author":"Gidal","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2024.110171_bib34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.bdj.4801369","article-title":"A randomised crossover trial of post-operative cognitive and psychomotor recovery from benzodiazepine sedation: effects of reversal with flumazenil over a prolonged recovery period","volume":"192","author":"Girdler","year":"2002","journal-title":"Br. Dent. J."},{"key":"10.1016\/j.neuropharm.2024.110171_bib35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tips.2022.04.008","article-title":"Countermeasures in organophosphorus intoxication: pitfalls and prospects","volume":"43","author":"Gorecki","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110171_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0735-6757(99)90079-7","article-title":"Prehospital stability of diazepam and lorazepam","volume":"17","author":"Gottwald","year":"1999","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2024.110171_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00000542-198461010-00006","article-title":"Effect of age, gender, and obesity on midazolam kinetics","volume":"61","author":"Greenblatt","year":"1984","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2024.110171_bib38","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1007\/BF01918828","article-title":"Peptido-aminobenzophenones-novel latentiated benzo-1,4-diazepines","volume":"33","author":"Hassall","year":"1977","journal-title":"Experientia"},{"key":"10.1016\/j.neuropharm.2024.110171_bib39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/cpt1974163part1479","article-title":"Diazepam metabolism in normal man. I. Serum concentrations and clinical effects after intravenous, intramuscular, and oral administration","volume":"16","author":"Hillestad","year":"1974","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2024.110171_bib40","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/epi.16506","article-title":"Pharmacokinetics and safety of VALTOCO (NRL-1; diazepam nasal spray) in patients with epilepsy during seizure (ictal\/peri-ictal) and nonseizure (interictal) conditions: a phase 1, open-label study","volume":"61","author":"Hogan","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2024.110171_bib41","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/j.1875-9114.1985.tb03411.x","article-title":"Midazolam: the first water-soluble benzodiazepine. Pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia","volume":"5","author":"Kanto","year":"1985","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.neuropharm.2024.110171_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.emc.2014.09.010","article-title":"Organophosphate and carbamate poisoning","volume":"33","author":"King","year":"2015","journal-title":"Emerg. Med. Clin."},{"key":"10.1016\/j.neuropharm.2024.110171_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/biof.2048","article-title":"N-methyl-d-aspartate receptors: structure, function, and role in organophosphorus compound poisoning","author":"Koli\u0107","year":"2024","journal-title":"BioFactors Oxf. Engl"},{"key":"10.1016\/j.neuropharm.2024.110171_bib44","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1152\/jn.00949.2009","article-title":"Central cholinesterase inhibition enhances glutamatergic synaptic transmission","volume":"103","author":"Kozhemyakin","year":"2010","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12028-011-9668-7","article-title":"Early ketamine to treat refractory status epilepticus","volume":"16","author":"Kramer","year":"2012","journal-title":"Neurocritical Care"},{"key":"10.1016\/j.neuropharm.2024.110171_bib46","article-title":"Midazolam and other benzodiazepines","author":"Kt","year":"2008","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib47","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.bbadis.2018.05.016","article-title":"Benzodiazepine-refractory status epilepticus, neuroinflammation, and interneuron neurodegeneration after acute organophosphate intoxication","volume":"1864","author":"Kuruba","year":"2018","journal-title":"Biochim. Biophys. Acta BBA - Mol. Basis Dis."},{"key":"10.1016\/j.neuropharm.2024.110171_bib48","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0006-8993(91)91539-D","article-title":"Effects of soman-induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus","volume":"563","author":"Lallement","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110171_bib49","author":"Laney","year":"2018"},{"key":"10.1016\/j.neuropharm.2024.110171_bib50","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jama.290.5.659","article-title":"Clinical manifestations of sarin nerve gas exposure","volume":"290","author":"Lee","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2024.110171_bib51","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/0091270007311572","article-title":"Bioavailability and dose proportionality of intramuscular diazepam administered by autoinjector","volume":"48","author":"Lehmann","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109294","article-title":"Sublingual lorazepam as rescue therapy for seizure emergencies in adults","volume":"145","author":"Lelis","year":"2023","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2024.110171_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108444","article-title":"Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors","volume":"185","author":"Lumley","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.110171_bib54","first-page":"37","article-title":"Evaluation of the anxiolytic and amnestic effects of diazepam and midazolam for minor oral surgery. Anesth","volume":"34","author":"Luyk","year":"1987","journal-title":"Prog."},{"key":"10.1016\/j.neuropharm.2024.110171_bib55","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2174\/138920008786049258","article-title":"Benzodiazepine metabolism: an analytical perspective","volume":"9","author":"Mandrioli","year":"2008","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib56","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/pan.13747","article-title":"Efficacy of oral midazolam for minimal and moderate sedation in pediatric patients: a systematic review","volume":"29","author":"Manso","year":"2019","journal-title":"Paediatr. Anaesth."},{"key":"10.1016\/j.neuropharm.2024.110171_bib57","article-title":"Ketamine as adjunct to midazolam treatment following soman-induced status epilepticus reduces seizure severity, epileptogenesis, and brain pathology in plasma carboxylesterase knockout mice","volume":"111","author":"Marrero-Rosado","year":"2020","journal-title":"Epilepsy Behav. EB"},{"key":"10.1016\/j.neuropharm.2024.110171_bib58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00139709-200322020-00002","article-title":"Diazepam in the treatment of organophosphorus ester pesticide poisoning","volume":"22","author":"Marrs","year":"2003","journal-title":"Toxicol. Rev."},{"key":"10.1016\/j.neuropharm.2024.110171_bib59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0163-7258(93)90066-M","article-title":"Organophosphate poisoning","volume":"58","author":"Marrs","year":"1993","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2024.110171_bib60","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/01480540903483417","article-title":"Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in Guinea pigs","volume":"33","author":"McDonough","year":"2010","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib61","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0149-7634(96)00050-4","article-title":"Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology","volume":"21","author":"McDonough","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2024.110171_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1742-7843.2008.00326.x","article-title":"Comparison of the intramuscular, intranasal or sublingual routes of midazolam administration for the control of soman-induced seizures","volume":"104","author":"McDonough","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib63","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s002040050637","article-title":"Comparative evaluation of benzodiazepines for control of soman-induced seizures","volume":"73","author":"McDonough","year":"1999","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib64","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(05)66909-7","article-title":"Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial","volume":"366","author":"McIntyre","year":"2005","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.neuropharm.2024.110171_bib65","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1553-2712.2010.00751.x","article-title":"Midazolam versus diazepam for the treatment of status epilepticus in children and young adults: a meta-analysis","volume":"17","author":"McMullan","year":"2010","journal-title":"Acad. Emerg. Med. Off. J. Soc. Acad. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2024.110171_bib66","article-title":"Psychosocial outcomes of repeated treatment of seizure clusters with midazolam nasal spray: results of a phase 3, open-label extension trial","volume":"138","author":"Meng","year":"2023","journal-title":"Epilepsy Behav. EB"},{"key":"10.1016\/j.neuropharm.2024.110171_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.732213","article-title":"Refractory and super-refractory status epilepticus in nerve agent-poisoned rats following application of standard clinical treatment guidelines","volume":"15","author":"Morgan","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110171_bib68","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1542\/peds.2007-0930","article-title":"Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: a randomized clinical trial","volume":"121","author":"Mpimbaza","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2024.110171_bib69","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2017.04.019","article-title":"Simultaneous triple therapy for the treatment of status epilepticus","volume":"104","author":"Niquet","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2024.110171_bib70","first-page":"1103","article-title":"The effects of age and gender on the optimal premedication dose of intramuscular midazolam","volume":"86","author":"Nishiyama","year":"1998","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2024.110171_bib71","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0736-4679(97)00022-X","article-title":"Midazolam: a review of therapeutic uses and toxicity","volume":"15","author":"Nordt","year":"1997","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2024.110171_bib72","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF01242464","article-title":"Spectrophotometric study of the acid-base equilibria of an imidazobenzodiazepine, midazolam, and its determination in pharmaceutical formulations","volume":"97","author":"Orive","year":"1989","journal-title":"Microchim. Acta"},{"key":"10.1016\/j.neuropharm.2024.110171_bib73","first-page":"14","article-title":"First-pass metabolism of midazolam by the human intestine","volume":"60","author":"Paine","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2024.110171_bib74","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00134-001-1125-1","article-title":"Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy","volume":"28","author":"Parker","year":"2002","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.neuropharm.2024.110171_bib75","article-title":"Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters: results from an exit survey of a phase 3, open-label, repeat-dose safety study","volume":"121","author":"Penovich","year":"2021","journal-title":"Epilepsy Behav. EB"},{"key":"10.1016\/j.neuropharm.2024.110171_bib76","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00204-022-03397-w","article-title":"Neurotoxicity evoked by organophosphates and available countermeasures","volume":"97","author":"Pulkrabkova","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib77","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/epi.12989","article-title":"Midazolam as an anticonvulsant antidote for organophosphate intoxication\u2014a pharmacotherapeutic appraisal","volume":"56","author":"Reddy","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2024.110171_bib78","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0404.2008.01004.x","article-title":"Benzodiazepines in epilepsy: pharmacology and pharmacokinetics","volume":"118","author":"Riss","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.neuropharm.2024.110171_bib79","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1007\/s10072-021-05468-9","article-title":"Rescue therapies for seizure emergencies: current and future landscape","volume":"42","author":"Samanta","year":"2021","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110171_bib80","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.taap.2012.01.017","article-title":"The anticholinergic and antiglutamatergic drug caramiphen reduces seizure duration in soman-exposed rats: synergism with the benzodiazepine diazepam","volume":"259","author":"Schultz","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib82","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(98)06425-3","article-title":"Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial","volume":"353","author":"Scott","year":"1999","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.neuropharm.2024.110171_bib83","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/15376516.2018.1558322","article-title":"Comparative effects of scopolamine and phencynonate on organophosphorus nerve agent-induced seizure activity, neuropathology and lethality","volume":"29","author":"Shih","year":"2019","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.neuropharm.2024.110171_bib84","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0149-7634(05)80028-4","article-title":"Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms","volume":"15","author":"Shih","year":"1991","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2024.110171_bib85","first-page":"86","article-title":"Anticonvulsants for soman-induced seizure activity","volume":"6","author":"Shih","year":"1999","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neuropharm.2024.110171_bib86","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2024.110171_bib87","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.tox.2014.05.010","article-title":"Prevention of organophosphate-induced chronic epilepsy by early benzodiazepine treatment","volume":"323","author":"Shrot","year":"2014","journal-title":"Toxicology"},{"key":"10.1016\/j.neuropharm.2024.110171_bib88","series-title":"A Double-Blind Randomized Clinical Trial of the Efficacy of IM Midazolam versus IV Lorazepam in the Pre-hospital Treatment of Status Epilepticus by Paramedics (Clinical Trial Registration No. results\/NCT00809146)","author":"Silbergleit","year":"2016"},{"key":"10.1016\/j.neuropharm.2024.110171_bib89","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 8","key":"10.1016\/j.neuropharm.2024.110171_bib90","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2011.03235.x","article-title":"RAMPART (Rapid Anticonvulsant Medication Prior to Arrival Trial): a double-blind randomized clinical trial of the efficacy of intramuscular midazolam versus intravenous lorazepam in the prehospital treatment of status epilepticus by paramedics","volume":"52","author":"Silbergleit","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2024.110171_bib91","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1124\/jpet.120.000175","article-title":"Delayed adjunctive treatment of organophosphate-induced status epilepticus in rats with phenobarbital, memantine, or dexmedetomidine","volume":"375","author":"Spampanato","year":"2020","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.110171_bib92","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(20)32644-1","article-title":"Novichok nerve agent poisoning","volume":"397","author":"Steindl","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2024.110171_bib93","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/bja\/aen251","article-title":"Effects of age and gender on intravenous midazolam premedication: a randomized double-blind study","volume":"101","author":"Sun","year":"2008","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2024.110171_bib94","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0736-4679(98)00170-X","article-title":"Use of intramuscular midazolam for status epilepticus11Pharmacology in Emergency Medicine is coordinated by Richard F. Clark, md, of the University of California San Diego Medical Center, San Diego, California","volume":"17","author":"Towne","year":"1999","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2024.110171_bib95","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/bcp.12693","article-title":"Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents","volume":"80","author":"van Rongen","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib96","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/jnnp.37.7.841","article-title":"Neurological manifestations of organophosphorous insecticide poisoning","volume":"37","author":"Wadia","year":"1974","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2024.110171_bib97","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00000542-199102000-00007","article-title":"Plasma concentrations of midazolam in children following intranasal administration","volume":"74","author":"Walbergh","year":"1991","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2024.110171_bib98","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1177\/00912700122012779","article-title":"Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration","volume":"41","author":"Wermeling","year":"2001","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib99","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/epi.16300","article-title":"Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters: an open-label extension trial","volume":"60","author":"Wheless","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2024.110171_bib100","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/epi.17041","article-title":"Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy","volume":"62","author":"Wheless","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2024.110171_bib101","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4140\/TCP.n.2013.538","article-title":"The history of benzodiazepines","volume":"28","author":"Wick","year":"2013","journal-title":"Consult. Pharm."},{"key":"10.1016\/j.neuropharm.2024.110171_bib102","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bcp.2004.07.038","article-title":"Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes","volume":"68","author":"Worek","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib103","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s00204-016-1772-1","article-title":"Toxicology of organophosphorus compounds in view of an increasing terrorist threat","volume":"90","author":"Worek","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2024.110171_bib104","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0196-0644(05)80203-3","article-title":"Comparison of midazolam and diazepam for conscious sedation in the emergency department","volume":"22","author":"Wright","year":"1993","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2024.110171_bib105","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1124\/jpet.117.247106","article-title":"Midazolam-resistant seizures and brain injury after acute intoxication of diisopropylfluorophosphate, an organophosphate pesticide and surrogate for nerve agents","volume":"367","author":"Wu","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.110171_bib106","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1525-139X.2007.00280.x","article-title":"Recognition, treatment, and prevention of propylene glycol toxicity","volume":"20","author":"Zar","year":"2007","journal-title":"Semin. Dial."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082400340X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082400340X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:38:41Z","timestamp":1777426721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082400340X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":105,"alternative-id":["S002839082400340X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110171","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Midazolam - A diazepam replacement for the management of nerve agent-induced seizures","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110171"}}